Nomograms for preoperative prediction of axillary nodal status in breast cancer. BJS 2017; 104: 1494-1505.
Published: 18th July 2017
Authors: L. Dihge, P.‐O. Bendahl, L. Rydén
Axillary staging in patients with breast cancer and clinically node‐negative disease is performed by sentinel node biopsy (
Patients presenting to Skåne University Hospital, Lund, with breast cancer were included in a prospectively maintained registry between January 2009 and December 2012. Those with a preoperative diagnosis of nodal metastases were excluded. Patients with data on hormone receptor status, human epidermal growth factor receptor 2 and Ki‐67 expression were included to allow grouping into surrogate molecular subtypes. Based on logistic regression analyses, nomograms summarizing the strength of the associations between the predictors and each nodal status endpoint were developed. Predictive performance was assessed using the area under the receiver operating characteristic (
Of the 692 patients eligible for analysis, 248 were diagnosed with node‐positive disease. Molecular subtype, age, mode of detection, tumour size, multifocality and vascular invasion were identified as predictors of any nodal disease. Nomograms that included these predictors demonstrated good predictive abilities, and comparable performances in the internal validation; the area under the
The nomograms presented facilitate preoperative decision‐making regarding the extent of axillary surgery.Read more
You may also be interested in
Risk of death from breast cancer after treatment for ductal carcinoma in situ. BJS 2017; 104: 1506-1513.
Authors: C. Wadsten, H. Garmo, I. Fredriksson, M. Sund, F. Wärnberg
Notes: Rare, but worse for large tumours and uncertain margins
Authors: E. Botteri, P. Veronesi, J. Vila, N. Rotmensz, V. Galimberti, M. V. Thomazini et al.
Notes: Molecular subtype matters more
Authors: J. R. Benson, S. K. Down
Authors: R. V. Dave, R. Millican‐Slater, D. Dodwell, K. Horgan, N. Sharma
Notes: Mid‐neoadjuvant chemotherapy MRI useful
Combined PET–CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node‐positive breast cancer after neoadjuvant therapy. BJS 2017; 104: 1188-1196.
Authors: B. B. Koolen, M. Donker, M. E. Straver, M. E. M. van der Noordaa, E. J. T. Rutgers, R. A. Valdés Olmos et al.
Notes: Reduced axillary lymph node dissection rates
Quality of life after mastectomy with or without immediate breast reconstruction. BJS 2017; 104: 1197-1206.
Authors: J. Dauplat, F. Kwiatkowski, P. Rouanet, E. Delay, K. Clough, J. L. Verhaeghe et al.
Notes: Good for the appropriate patient
Authors: C. Liedtke, H.‐C. Kolberg
Association between age and access to immediate breast reconstruction in women undergoing mastectomy for breast cancer. BJS 2017; 104: 555-561.
Authors: R. Jeevan, J. P. Browne, C. Gulliver‐Clarke, J. Pereira, C. M. Caddy, J. H. P. van der Meulen et al.
Notes: Age should not matter
Ten‐year report on axillary recurrence after negative sentinel node biopsy for breast cancer from the Swedish Multicentre Cohort Study. BJS 2017; 104: n/a-n/a.
Authors: J. de Boniface, J. Frisell, L. Bergkvist, Y. Andersson
Notes: Axillary recurrences rare
Authors: K.‐T. Lee, S. I. Bang, J.‐K. Pyon, J. H. Hwang, G.‐H. Mun
Notes: Implants increase risk
Meta‐analysis of sentinel lymph node biopsy in breast cancer using the magnetic technique. BJS 2016; 103: 1409-1419.
Authors: A. Zada, M. C. L. Peek, M. Ahmed, B. Anninga, R. Baker, M. Kusakabe et al.
Notes: Both work
Authors: J. Brandt, S. Borgquist, M. Almquist, J. Manjer
Notes: Hypothyroidism reduces survival